Iovance Biotherapeutics I... (IOVA)
NASDAQ: IOVA
· Real-Time Price · USD
2.54
0.09 (3.67%)
At close: Aug 15, 2025, 3:59 PM
2.58
1.38%
After-hours: Aug 15, 2025, 06:54 PM EDT
Iovance Biotherapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 59.95M | 49.32M | 73.69M | 58.55M | 31.11M | 715K | 482K | 469K | 238K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 56.66M | 49.74M | 45.54M | 39.82M | 31.37M | 7.26M | 14.08M | 4.34M | 2.05M | 5.7M | 5.71M | n/a | 5.2M | 4.98M | 4.58M | 6.25M | 488K | 2.66M |
Gross Profit | 3.29M | -417K | 28.15M | 18.73M | -262K | -6.55M | -13.6M | -3.87M | -1.81M | -5.7M | -5.71M | n/a | -5.2M | -4.98M | -4.58M | -6.25M | -488K | -2.66M |
Operating Income | -113.77M | -121.22M | -86.58M | -89.07M | -101.91M | -117.72M | -121.26M | -118.36M | -110.09M | -110.86M | -107.04M | -100.39M | -99.73M | -91.71M | -99.47M | -86.24M | -81.43M | -75.57M |
Interest Income | 4.1M | 3.22M | 9.57M | 4M | 3.35M | 3.34M | 3.12M | 3.36M | 3.08M | 3.49M | 1.72M | 777K | 385K | 106K | 135K | 120K | 75K | 121K |
Pretax Income | -109.67M | -118M | -77M | -85.06M | -98.56M | -114.38M | -118.14M | -115M | -107M | -107.37M | -105.32M | -99.62M | -99.35M | -91.61M | -99.33M | -86.12M | -81.35M | -75.45M |
Net Income | -111.66M | -116.16M | -78.56M | -83.54M | -97.1M | -112.98M | -116.38M | -113.76M | -106.53M | -103.88M | -101.89M | -99.62M | -98.96M | -91.5M | -99.33M | -86.12M | -81.35M | -75.45M |
Selling & General & Admin | 37.7M | 43.92M | 42.5M | 39.55M | 34.19M | 26.12M | 20.19M | 26.96M | 21.93M | 28.12M | 26.46M | 27.89M | 26.33M | 23.41M | 23.85M | 20.89M | 19.31M | 19.62M |
Research & Development | 79.36M | 76.88M | 72.22M | 68.25M | 62.08M | 79.78M | 87.47M | 87.53M | 86.35M | 82.73M | 80.57M | 72.5M | 73.41M | 68.3M | 75.62M | 65.36M | 62.12M | 55.95M |
Other Expenses | n/a | n/a | n/a | -1K | 5.38M | 5.27M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 117.06M | 120.8M | 114.73M | 107.8M | 101.65M | 111.18M | 107.66M | 114.49M | 108.27M | 110.86M | 107.04M | 100.39M | 99.73M | 91.71M | 99.47M | 86.24M | 81.43M | 75.57M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | 33.35M | -16.21M | n/a | n/a | 17.86M | -29.13M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 173.73M | 170.54M | 160.27M | 147.62M | 133.02M | 118.44M | 121.74M | 118.83M | 110.32M | 110.86M | 107.04M | 100.39M | 99.73M | 91.71M | 99.47M | 86.24M | 81.43M | 75.57M |
Income Tax Expense | 1.99M | -1.84M | 1.56M | -1.52M | -1.46M | -1.41M | -1.76M | -1.24M | -477K | -3.49M | -3.43M | n/a | -385K | -106K | n/a | n/a | -122K | n/a |
Shares Outstanding (Basic) | 334.51M | 322.87M | 304.89M | 303.27M | 284.82M | 266.22M | 255.95M | 245.82M | 224.48M | 213.69M | 164.76M | 157.82M | 157.27M | 157.11M | 156.92M | 155.51M | 153.75M | 147.37M |
Shares Outstanding (Diluted) | 334.51M | 322.87M | 304.89M | 303.27M | 284.82M | 266.22M | 255.95M | 245.82M | 224.48M | 213.69M | 164.76M | 157.82M | 157.27M | 157.11M | 156.92M | 155.51M | 153.75M | 147.37M |
EPS (Basic) | -0.33 | -0.36 | -0.26 | -0.28 | -0.34 | -0.42 | -0.45 | -0.46 | -0.47 | -0.5 | -0.62 | -0.63 | -0.63 | -0.58 | -0.63 | -0.55 | -0.53 | -0.51 |
EPS (Diluted) | -0.33 | -0.36 | -0.26 | -0.28 | -0.34 | -0.42 | -0.45 | -0.46 | -0.47 | -0.5 | -0.62 | -0.63 | -0.63 | -0.58 | -0.63 | -0.55 | -0.53 | -0.51 |
EBITDA | -101.84M | -106.94M | -74.89M | -77.92M | -91.05M | -107.81M | -111.54M | -108.49M | -102.25M | -105.16M | -101.33M | -95.19M | -94.49M | -86.73M | -87.25M | -82.28M | -78.65M | -72.8M |
EBIT | -113.77M | -118M | -86.58M | -89.07M | -101.91M | -117.72M | -118.14M | -115M | -107M | -110.86M | -107.04M | -100.39M | -99.73M | -91.71M | -99.33M | -86.12M | -81.35M | -75.45M |
Depreciation & Amortization | 11.94M | 11.06M | 11.69M | 11.15M | 10.86M | 9.91M | 9.71M | 6.93M | 4.86M | 5.7M | 5.71M | 5.2M | 5.2M | 4.98M | 12.21M | 3.96M | 2.78M | 372K |